Pathology and cancer leaders from the UK and across Europe met in London in May at a Philips Digital Pathology Workshop to learn how a Lean-based business tool can be used to build the case for digital pathology.
Digital pathology aims to reduce pressure on pathology services by streamlining workflow and extending collaboration, with the further aim of increasing diagnostic confidence. European histopathologists have already given a lead in demonstrating the value of digital pathology. Since 2014, the CE-IVD mark has allowed its use in primary diagnosis. In Europe, digital pathology is already recognised for increased efficiencies in the logistics and consultation needs in primary diagnosis of histopathology images.1,2
News from the USA that the Food and Drug Administration (FDA) has now cleared the first whole-slide imaging system for digital pathology, enabling its use in primary diagnostics, is a significant leap forward for pathology services worldwide, and is expected to boost adoption. The decision was based on one of the largest studies ever conducted to compare the use of digital pathology to optical microscopes. The FDA evaluated data from a clinical study of approximately 2000 surgical pathology cases, and involved 16 pathologists at four clinical study sites.
Digital pathology image creation
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.